Authors

States Grant Prescribing Authority to Psychologists

This movement has aimed to address the mental health care epidemic in the United States.

Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.

Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes

The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.

Getting the Right Biomarker Test at the Right Time in Lung Cancer Care

Optimizing biomarker testing workflows and pharmacist involvement can improve precision oncology decision-making in non–small cell lung cancer.

Expanding Contraceptive Prescribing Authority in Wisconsin to Increase Birth Control Access

Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.

Sotatercept Demonstrates Its Potential in the Phase 3 ZENITH Trial

Marc Humbert, MD, PhD, shared data that were presented at the ACC 2025 Scientific Sessions.

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Cimerli offers a promising biosimilar treatment for age-related macular degeneration, enhancing vision preservation with its effective VEGF inhibition.

From Diagnosis to Therapy: Pharmacists Can Help Close the Gap in Colorectal Cancer Treatment

Michael Arnold, PharmD, discussed the role of oncology pharmacists in enhancing biomarker testing for patients with metastatic colorectal cancer.

Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm

This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.

Standardizing Supplement Recommendations in a Neuro-Oncology Clinic: A Pharmacist-Led Quality Improvement Initiative

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Better Asthma Control Starts at the Pharmacy: Evidence, Interventions, and Outcomes

Community pharmacists boost asthma control by improving adherence, inhaler technique, and access—cutting exacerbations and emergency department visits.

A New Gut Feeling: Where Might Vonoprazan Fit in Therapy?

Beyond the Prescription: How Pharmacists Address Social Barriers to Diabetes Care

Disparities in education access and quality, income level, and race and ethnicity are SDoH that make a major impact on diabetes and its management in the US.

Pediatric Amoxicillin Dosing: A Guide for Indication-Based Dose Selection

Amoxicillin is a favorable choice for outpatient use in pediatric patients given its relatively narrow spectrum of activity and palatable formulation.

Dry Mouth: Its Etiology, Symptoms, and Strategies for Management

Pharmacists with a deeper knowledge of xerostomia are ideally positioned to help educate patients with dry mouth on making informed self-care decisions for effective symptom management and improved quality of life.

Unlocking PROTACs’ Potential: Overcoming Development Challenges

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.

Adapting AI Prescreening Approaches to Advance 340B Operations

AI enhances 340B program management by optimizing data analysis, improving accuracy, and streamlining operations for better patient care and compliance.

RSV in Older Adults: The More You Know, the Better Off Your Patients Will Be

Respiratory syncytial virus hits older adults hard and is often missed. Learn symptoms, testing, and how new vaccines and pharmacists help prevent severe illness.

Bridging the Gap: How Housing Status and Race Shape Cancer Screening Disparities

Pharmacy Times interviewed Kimlin Ashing and Narissa Nonzee about their work examining how housing status, race, and ethnicity drive cancer screening disparities.

How MammaPrint Is Reshaping Treatment Decisions in HR+/HER2– Breast Cancer

MammaPrint genomic profiling guides personalized HR-positive breast cancer treatment, helping pharmacists and oncology teams reduce chemotherapy use while protecting outcomes.

Potential Safety Concerns With Evinacumab

This case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.

Drafts, Laughs, and Lasting Lessons: Inside a Unique Medical Writing Experience

The University of Connecticut's Medical Writing Certificate program transforms aspiring writers into confident communicators through hands-on training and real-world experience.

Addressing Loneliness: Pharmacy’s Revolution as a Community Wellness Hub

As loneliness becomes a global health threat, pharmacies can take the social responsibility to combat isolation crisis and champion the community's health.

Op-Ed: Expand Patient Choice to Lower Medication Costs

Retirement Planning: More Than the Math

Pharmacists rethink retirement: use compound growth, start early, and define the life you want—so your savings plan fits your future.

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Cost Avoidance and Satisfaction Associated With Clinical Pharmacy Services in a Veterans Affairs Specialty Clinic

An infusion and specialty clinical pharmacist is a valuable integrated member of the health care team as demonstrated by cost avoidance and high satisfaction reported by both veterans and specialty providers.

Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy

Pembrolizumab in adjuvant NSCLC therapy can trigger central adrenal insufficiency with vague fatigue, nausea, and hyponatremia.